Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Vitruvias Therapeutics
Vitruvias Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Vitruvias Therapeutics
Total Funding
$12.5 M
Vitruvias Therapeutics Summary
Company Summary
Overview
Vitruvias Therapeutics is a generic pharmaceutical company with a focus on developing niche topical generic products that are sold only by prescription.
Type
Private
Status
Active
Founded
2013
HQ
Auburn, AL, US
|
view all locations
Website
http://vitruvias.com
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
genetics
Homepage
Linkedin
Table of Contents
Key People
Locations
Competitors
Key People
Carl L. Whatley,
CEO, Co-Founder and Chairman of the Board
Lisa Apolis,
Senior Director Regulatory Affairs
Linkedin
Jose Suarez,
Senior Director Manufacturing and Supply Chain
Linkedin
Katie Carroll,
Director- Regulatory Affairs and Pharmacovigilance
and 3 others
Locations
View all
1 location detected
Auburn, AL
HQ
United States
785 N Dean Rd Ste 600
Competitors and Similar Companies
Expansion Therapeutics
Healthcare - Private
Neuron23
Healthcare - Private
Bluebird Bio
Healthcare - Public
Sarepta Therapeutics
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top